Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients

International Journal of Colorectal Disease

Volumn 22, Issue 11, 2007, Pages 1331-1338

  Angenete, Eva ^a   Langenskiöld, Marcus ^a   Palmgren, Ingrid ^a   Falk, Peter ^a   Öresland, Tom ^a   Ivarsson, Marie Louise ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Distant metastases; Extracellular matrix; Irradiation; Rectal cancer; TGF beta

Indexed keywords

ANTIBIOTIC AGENT; FLUOROURACIL; FOLINIC ACID; LOW MOLECULAR WEIGHT HEPARIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; POSTOPERATIVE INFECTION; POSTOPERATIVE THROMBOSIS; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION RESPONSE; RECTUM BIOPSY; RECTUM CANCER; RECTUM MUCOSA; RECTUM SURGERY; RECURRENCE RISK; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 34648829019     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0342-7     Document Type: Article

References (27)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
2. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (1997) Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987
3. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U (2005) Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 23:5644-5650
4. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23:6126-6131
5. Cedermark B, Johansson H, Rutqvist LE, Wilking N (1995) The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group. Cancer 75:2269-2275
6. Cedermark B, Theve NO, Rieger A, Wahren B, Glas JE, Rubio C, Ost A, Brostrom L, Ekelund G, Forsgren L et al (1985) Preoperative short-term radiotherapy in rectal carcinoma. A preliminary report of a prospective randomized study. Cancer 55:1182-1185
7. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B (2005) Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish rectal cancer trial. J Clin Oncol 23:8697-8705
8. Lawrence DA (2001) Latent-TGF-beta: An overview. Mol Cell Biochem 219:163-170
9. Hill RP, Rodemann HP, Hendry JH, Roberts SA, Anscher MS (2001) Normal tissue radiobiology: From the laboratory to the clinic. Int J Radiat Oncol Biol Phys 49:353-365
10. Wang J, Zheng H, Sung CC, Richter KK, Hauer-Jensen M (1998) Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy. Am J Pathol 153:1531-1540
11. Denham JW, Hauer-Jensen M (2002) The radiotherapeutic injury - a complex 'wound'. Radiother Oncol 63:129-145
12. Wu SP, Theodorescu D, Kerbel RS, Willson JK, Mulder KM, Humphrey LE, Brattain MG (1992) TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol 116:187-196
13. Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A (1995) High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 4:549-554
14. Narai S, Watanabe M, Hasegawa H, Nishibori H, Endo T, Kubota T, Kitajima M (2002) Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer. Int J Cancer 97:508-511
15. Tsushima H, Ito N, Tamura S, Matsuda Y, Inada M, Yabuuchi I, Imai Y, Nagashima R, Misawa H, Takeda H, Matsuzawa Y, Kawata S (2001) Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res 7:1258-1262
16. Tsamandas AC, Kardamakis D, Ravazoula P, Zolota V, Salakou S, Tepetes K, Kalogeropoulou C, Tsota I, Kourelis T, Makatsoris T, Karavias D, Scopa CD, Bonikos DS, Kalofonos HP, Petsas T (2004) The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival. Strahlenther Onkol 180:201-208
17. Ivarsson ML, Bergstrom M, Eriksson E, Risberg B, Holmdahl L (1998) Tissue markers as predictors of postoperative adhesions. Br J Surg 85:1549-1554
18. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y, Matsuzawa Y (1996) High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110:375-382
19. Richter KK, Fink LM, Hughes BM, Shmaysani HM, Sung CC, Hauer-Jensen M (1998) Differential effect of radiation on endothelial cell function in rectal cancer and normal rectum. Am J Surg 176:642-647
20. Johnson LB, Adawi D, Agren MS, Jorgensen LN, Wittgren L, Mattsson S, Blomquist P, Gottrup F, Jeppsson B (2006) Combination of pre-operative radiotherapy and surgery suppresses local accumulation of collagen and TGF-beta1 in rats. J Surg Res 133:136-142
21. Barcellos-Hoff MH (1993) Radiation-induced transforming growth factor beta and subsequent extracellular matrix reorganization in murine mammary gland. Cancer Res 53:3880-3886
22. Angenete E, Langenskiold M, Falk P, Ivarsson ML (2007) Matrix metalloproteinases in rectal mucosa, tumour and plasma: Response after preoperative irradiation. Int J Colorectal Dis (in press)
23. Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176
24. Dahlberg M, Glimelius B, Graf W, Pahlman L (1998) Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum 41:543-549 discussion 549-551
25. Holm T, Singnomklao T, Rutqvist LE, Cedermark B (1996) Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 78:968-976
26. Kushiyama Y, Fukuda R, Suetsugu H, Kazumori H, Ishihara S, Adachi K, Kinoshita Y (2000) Site-dependent production of transforming growth factor beta1 in colonic mucosa: Its possible role in tumorigenesis of the colon. J Lab Clin Med 136:201-208
27. Shim KS, Kim KH, Han WS, Park EB (1999) Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection. Cancer 85:554-561